Share Price and Basic Stock Data
Last Updated: February 16, 2026, 8:27 pm
| PEG Ratio | 1.75 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Haryana Leather Chemicals Ltd operates in the specialty chemicals sector, focusing on leather processing chemicals. The company reported a market capitalization of ₹30.6 Cr and a current share price of ₹62.2. Over the past fiscal year, Haryana Leather Chemicals recorded a sales revenue of ₹42.48 Cr, which is expected to rise to ₹44.42 Cr in FY 2024 and ₹49.03 Cr in FY 2025. This upward trend reflects a consistent recovery from the pandemic-induced downturn, with quarterly sales showing an increase from ₹9.87 Cr in September 2022 to ₹11.41 Cr in September 2023. This represents a year-on-year growth of approximately 15.5%. The company’s operational capacity appears to be improving, with a notable rise in quarterly sales observed in March 2024, where it reached ₹13.53 Cr. This growth trajectory positions Haryana Leather Chemicals favorably within the competitive landscape of specialty chemicals, where demand for innovative and sustainable solutions is on the rise.
Profitability and Efficiency Metrics
Haryana Leather Chemicals reported an operating profit margin (OPM) of 6.65% and a return on equity (ROE) of 5.45%. The company’s net profit for the trailing twelve months (TTM) was ₹1.93 Cr, with earnings per share (EPS) standing at ₹4.69 for FY 2025. The company’s efficiency metrics show a cash conversion cycle (CCC) of 79.42 days, indicating moderate operational efficiency as compared to industry norms. The interest coverage ratio (ICR) was exceptionally high at 56.43x, reflecting strong capability in covering interest obligations. However, the OPM has shown variability, peaking at 20.18% in March 2024 before declining to 6.65% in the latest quarter. This fluctuation may signal challenges in cost management or pricing pressures. The reported net profit margin of 4.69% for FY 2025 suggests that while profitability exists, there is room for improvement to align with sector averages, which typically hover around 10% for specialty chemicals.
Balance Sheet Strength and Financial Ratios
The balance sheet of Haryana Leather Chemicals reveals a conservative financial structure, with total borrowings reported at just ₹0.52 Cr, reflecting a debt-to-equity ratio of 0.01. This low leverage indicates a strong reliance on equity financing, which is favorable for financial stability. The company’s reserves stood at ₹39.08 Cr, contributing to a book value per share of ₹87.45. The current ratio is robust at 3.84, suggesting excellent short-term liquidity, while the quick ratio of 3.10 further reinforces this strength. These figures are significantly above typical industry benchmarks, indicating that the company is well-positioned to meet its short-term obligations without liquidity concerns. However, the return on capital employed (ROCE) has shown a slight decline to 8.02%, which may suggest inefficiencies in utilizing capital for generating returns. The enterprise value (EV) of ₹25.36 Cr relative to net operating revenue of ₹51.37 Cr further emphasizes a sound valuation relative to operational performance.
Shareholding Pattern and Investor Confidence
Haryana Leather Chemicals’ shareholding structure reflects a diverse ownership base, with promoters holding 41.28% of the company. The public holds a significant 58.54%, indicating a healthy level of market participation and interest in the company’s operations. Domestic institutional investors (DIIs) have a minor stake of 0.12%, while foreign institutional investors (FIIs) are not represented in the shareholding pattern. The number of shareholders increased from 3,053 in December 2022 to 3,845 by September 2025, demonstrating growing investor confidence. This increase in shareholder count suggests a positive outlook among retail investors. However, the low institutional participation could be a concern, as it may limit the stock’s visibility and liquidity in the broader market. The stability in promoter holding amidst fluctuating public sentiment suggests a commitment to long-term growth, which can be a reassuring factor for potential investors.
Outlook, Risks, and Final Insight
The outlook for Haryana Leather Chemicals appears cautiously optimistic, driven by an upward trend in sales and a strong balance sheet. However, risks remain, particularly in terms of fluctuating operational metrics and market conditions. The variability in profit margins and the recent decline in OPM could hinder the company’s ability to maintain profitability amidst rising input costs. Additionally, the low institutional investor interest raises concerns regarding stock liquidity and potential volatility. To bolster growth, the company could focus on enhancing operational efficiencies and exploring new markets or product lines that align with industry trends towards sustainability. A strategic emphasis on innovation could mitigate risks associated with cost pressures. Overall, while Haryana Leather Chemicals has solid fundamentals and a positive growth trajectory, addressing these risks will be crucial for sustaining investor confidence and achieving long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 349 Cr. | 38.1 | 61.0/35.0 | 25.1 | 20.5 | 1.05 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 29.0 Cr. | 59.1 | 88.8/52.0 | 14.1 | 89.6 | 1.69 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 46.4 Cr. | 683 | 899/600 | 15.6 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,178 Cr. | 70.1 | 111/68.2 | 22.7 | 22.0 | 0.71 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 599 Cr. | 240 | 350/208 | 22.9 | 93.8 | 1.04 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,962.36 Cr | 733.20 | 84.09 | 182.87 | 0.47% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.87 | 10.09 | 10.88 | 11.02 | 11.41 | 10.63 | 13.53 | 12.20 | 10.81 | 12.60 | 13.92 | 11.76 | 13.09 |
| Expenses | 9.46 | 9.56 | 10.07 | 10.46 | 10.60 | 9.55 | 10.80 | 11.45 | 10.10 | 12.11 | 12.75 | 10.97 | 12.22 |
| Operating Profit | 0.41 | 0.53 | 0.81 | 0.56 | 0.81 | 1.08 | 2.73 | 0.75 | 0.71 | 0.49 | 1.17 | 0.79 | 0.87 |
| OPM % | 4.15% | 5.25% | 7.44% | 5.08% | 7.10% | 10.16% | 20.18% | 6.15% | 6.57% | 3.89% | 8.41% | 6.72% | 6.65% |
| Other Income | 0.32 | 0.26 | 0.29 | 0.24 | -0.18 | 0.35 | 0.49 | 0.36 | -0.17 | 0.51 | 0.01 | 0.46 | -0.03 |
| Interest | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 | 0.00 | 0.03 |
| Depreciation | 0.18 | 0.19 | 0.23 | 0.19 | 0.18 | 0.18 | 0.32 | 0.20 | 0.22 | 0.23 | 0.25 | 0.24 | 0.26 |
| Profit before tax | 0.55 | 0.60 | 0.85 | 0.60 | 0.44 | 1.22 | 2.89 | 0.90 | 0.31 | 0.75 | 0.89 | 1.01 | 0.55 |
| Tax % | 23.64% | 25.00% | 31.76% | 28.33% | 38.64% | 18.03% | 18.34% | 28.89% | 51.61% | 18.67% | 55.06% | 26.73% | 67.27% |
| Net Profit | 0.42 | 0.45 | 0.58 | 0.43 | 0.27 | 1.01 | 2.37 | 0.65 | 0.15 | 0.61 | 0.40 | 0.74 | 0.18 |
| EPS in Rs | 0.86 | 0.92 | 1.18 | 0.88 | 0.55 | 2.06 | 4.83 | 1.32 | 0.31 | 1.24 | 0.81 | 1.51 | 0.37 |
Last Updated: January 7, 2026, 1:06 am
Below is a detailed analysis of the quarterly data for Haryana Leather Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 13.09 Cr.. The value appears strong and on an upward trend. It has increased from 11.76 Cr. (Jun 2025) to 13.09 Cr., marking an increase of 1.33 Cr..
- For Expenses, as of Sep 2025, the value is 12.22 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.97 Cr. (Jun 2025) to 12.22 Cr., marking an increase of 1.25 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.87 Cr.. The value appears strong and on an upward trend. It has increased from 0.79 Cr. (Jun 2025) to 0.87 Cr., marking an increase of 0.08 Cr..
- For OPM %, as of Sep 2025, the value is 6.65%. The value appears to be declining and may need further review. It has decreased from 6.72% (Jun 2025) to 6.65%, marking a decrease of 0.07%.
- For Other Income, as of Sep 2025, the value is -0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.46 Cr. (Jun 2025) to -0.03 Cr., marking a decrease of 0.49 Cr..
- For Interest, as of Sep 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Jun 2025) to 0.03 Cr., marking an increase of 0.03 Cr..
- For Depreciation, as of Sep 2025, the value is 0.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.24 Cr. (Jun 2025) to 0.26 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.55 Cr.. The value appears to be declining and may need further review. It has decreased from 1.01 Cr. (Jun 2025) to 0.55 Cr., marking a decrease of 0.46 Cr..
- For Tax %, as of Sep 2025, the value is 67.27%. The value appears to be increasing, which may not be favorable. It has increased from 26.73% (Jun 2025) to 67.27%, marking an increase of 40.54%.
- For Net Profit, as of Sep 2025, the value is 0.18 Cr.. The value appears to be declining and may need further review. It has decreased from 0.74 Cr. (Jun 2025) to 0.18 Cr., marking a decrease of 0.56 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.37. The value appears to be declining and may need further review. It has decreased from 1.51 (Jun 2025) to 0.37, marking a decrease of 1.14.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44.79 | 42.38 | 39.73 | 39.06 | 35.57 | 36.87 | 35.03 | 27.84 | 38.88 | 42.48 | 44.42 | 49.03 | 51.37 |
| Expenses | 41.22 | 39.07 | 36.17 | 35.99 | 33.45 | 35.23 | 32.84 | 26.07 | 37.64 | 40.29 | 41.40 | 46.41 | 48.05 |
| Operating Profit | 3.57 | 3.31 | 3.56 | 3.07 | 2.12 | 1.64 | 2.19 | 1.77 | 1.24 | 2.19 | 3.02 | 2.62 | 3.32 |
| OPM % | 7.97% | 7.81% | 8.96% | 7.86% | 5.96% | 4.45% | 6.25% | 6.36% | 3.19% | 5.16% | 6.80% | 5.34% | 6.46% |
| Other Income | 1.23 | 0.31 | 0.73 | 1.04 | 1.08 | 1.32 | 1.44 | 1.20 | 1.42 | 1.17 | 3.55 | 1.70 | 0.95 |
| Interest | 0.25 | 0.26 | 0.20 | 0.08 | 0.12 | 0.11 | 0.09 | 0.04 | 0.05 | 0.05 | 0.06 | 0.08 | 0.09 |
| Depreciation | 0.78 | 1.34 | 1.13 | 1.05 | 0.87 | 0.71 | 0.71 | 0.76 | 0.77 | 0.78 | 0.87 | 0.90 | 0.98 |
| Profit before tax | 3.77 | 2.02 | 2.96 | 2.98 | 2.21 | 2.14 | 2.83 | 2.17 | 1.84 | 2.53 | 5.64 | 3.34 | 3.20 |
| Tax % | 27.85% | 32.18% | 31.42% | 34.23% | 21.72% | 28.04% | 25.80% | 26.27% | 28.26% | 26.48% | 18.26% | 31.14% | |
| Net Profit | 2.72 | 1.36 | 2.03 | 1.96 | 1.73 | 1.54 | 2.09 | 1.60 | 1.31 | 1.86 | 4.62 | 2.30 | 1.93 |
| EPS in Rs | 5.54 | 2.77 | 4.14 | 3.99 | 3.52 | 3.14 | 4.26 | 3.26 | 2.67 | 3.79 | 9.41 | 4.69 | 3.93 |
| Dividend Payout % | 12.64% | 25.27% | 0.00% | 20.04% | 22.71% | 25.51% | 0.00% | 0.00% | 0.00% | 0.00% | 10.63% | 21.35% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 49.26% | -3.45% | -11.73% | -10.98% | 35.71% | -23.44% | -18.12% | 41.98% | 148.39% | -50.22% |
| Change in YoY Net Profit Growth (%) | 0.00% | 99.26% | -52.71% | -8.29% | 0.75% | 46.70% | -59.16% | 5.32% | 60.11% | 106.40% | -198.60% |
Haryana Leather Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: December 4, 2025, 3:02 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 |
| Reserves | 18.70 | 19.06 | 21.09 | 23.31 | 24.56 | 25.63 | 27.25 | 28.85 | 30.16 | 32.08 | 36.21 | 38.01 | 39.08 |
| Borrowings | 1.54 | 1.50 | 0.23 | 0.16 | 0.05 | 0.70 | 0.06 | 0.01 | 0.00 | 0.61 | 0.28 | 0.71 | 0.52 |
| Other Liabilities | 11.00 | 10.00 | 7.76 | 8.85 | 9.24 | 7.48 | 8.90 | 5.20 | 8.10 | 5.27 | 6.81 | 6.79 | 8.50 |
| Total Liabilities | 36.15 | 35.47 | 33.99 | 37.23 | 38.76 | 38.72 | 41.12 | 38.97 | 43.17 | 42.87 | 48.21 | 50.42 | 53.01 |
| Fixed Assets | 17.08 | 15.70 | 14.87 | 14.48 | 14.53 | 14.52 | 14.51 | 15.34 | 14.87 | 15.01 | 14.28 | 14.88 | 14.75 |
| CWIP | 0.05 | 0.03 | 0.09 | 0.22 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.19 | 0.04 | 0.15 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 19.02 | 19.74 | 19.03 | 22.53 | 24.22 | 24.20 | 26.61 | 23.63 | 28.30 | 27.74 | 33.74 | 35.50 | 38.11 |
| Total Assets | 36.15 | 35.47 | 33.99 | 37.23 | 38.76 | 38.72 | 41.12 | 38.97 | 43.17 | 42.87 | 48.21 | 50.42 | 53.01 |
Below is a detailed analysis of the balance sheet data for Haryana Leather Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.91 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.91 Cr..
- For Reserves, as of Sep 2025, the value is 39.08 Cr.. The value appears strong and on an upward trend. It has increased from 38.01 Cr. (Mar 2025) to 39.08 Cr., marking an increase of 1.07 Cr..
- For Borrowings, as of Sep 2025, the value is 0.52 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.71 Cr. (Mar 2025) to 0.52 Cr., marking a decrease of 0.19 Cr..
- For Other Liabilities, as of Sep 2025, the value is 8.50 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.79 Cr. (Mar 2025) to 8.50 Cr., marking an increase of 1.71 Cr..
- For Total Liabilities, as of Sep 2025, the value is 53.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 50.42 Cr. (Mar 2025) to 53.01 Cr., marking an increase of 2.59 Cr..
- For Fixed Assets, as of Sep 2025, the value is 14.75 Cr.. The value appears to be declining and may need further review. It has decreased from 14.88 Cr. (Mar 2025) to 14.75 Cr., marking a decrease of 0.13 Cr..
- For CWIP, as of Sep 2025, the value is 0.15 Cr.. The value appears strong and on an upward trend. It has increased from 0.04 Cr. (Mar 2025) to 0.15 Cr., marking an increase of 0.11 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 38.11 Cr.. The value appears strong and on an upward trend. It has increased from 35.50 Cr. (Mar 2025) to 38.11 Cr., marking an increase of 2.61 Cr..
- For Total Assets, as of Sep 2025, the value is 53.01 Cr.. The value appears strong and on an upward trend. It has increased from 50.42 Cr. (Mar 2025) to 53.01 Cr., marking an increase of 2.59 Cr..
Notably, the Reserves (39.08 Cr.) exceed the Borrowings (0.52 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 2.03 | 1.81 | 3.33 | 2.91 | 2.07 | 0.94 | 2.13 | 1.76 | 1.24 | 1.58 | 2.74 | 1.91 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 88.01 | 84.14 | 72.67 | 81.95 | 97.79 | 90.19 | 96.17 | 104.62 | 94.54 | 84.89 | 76.83 | 78.76 |
| Inventory Days | 44.72 | 67.39 | 51.75 | 51.13 | 63.62 | 40.37 | 50.70 | 37.75 | 45.47 | 38.03 | 40.07 | 48.44 |
| Days Payable | 90.36 | 86.63 | 63.75 | 92.44 | 108.57 | 72.05 | 103.49 | 56.12 | 65.99 | 38.26 | 51.45 | 47.78 |
| Cash Conversion Cycle | 42.37 | 64.91 | 60.66 | 40.64 | 52.84 | 58.51 | 43.39 | 86.25 | 74.01 | 84.65 | 65.45 | 79.42 |
| Working Capital Days | 57.61 | 64.59 | 55.12 | 46.44 | 66.19 | 63.46 | 57.62 | 83.78 | 75.10 | 76.56 | 65.74 | 71.17 |
| ROCE % | 14.74% | 9.09% | 12.22% | 11.21% | 8.01% | 7.21% | 9.14% | 6.64% | 5.49% | 7.10% | 8.96% | 8.02% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.69 | 9.41 | 3.79 | 2.68 | 3.26 |
| Diluted EPS (Rs.) | 4.69 | 9.41 | 3.79 | 2.68 | 3.26 |
| Cash EPS (Rs.) | 6.52 | 11.17 | 5.37 | 4.24 | 4.81 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 87.45 | 83.76 | 75.35 | 71.45 | 68.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 87.45 | 83.76 | 75.35 | 71.45 | 68.78 |
| Dividend / Share (Rs.) | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 |
| Revenue From Operations / Share (Rs.) | 99.89 | 90.50 | 86.54 | 79.20 | 56.72 |
| PBDIT / Share (Rs.) | 8.79 | 13.38 | 6.84 | 5.40 | 6.05 |
| PBIT / Share (Rs.) | 6.96 | 11.61 | 5.26 | 3.83 | 4.50 |
| PBT / Share (Rs.) | 6.80 | 11.50 | 5.16 | 3.74 | 4.41 |
| Net Profit / Share (Rs.) | 4.69 | 9.41 | 3.79 | 2.67 | 3.26 |
| PBDIT Margin (%) | 8.80 | 14.78 | 7.90 | 6.81 | 10.67 |
| PBIT Margin (%) | 6.96 | 12.83 | 6.07 | 4.83 | 7.93 |
| PBT Margin (%) | 6.81 | 12.70 | 5.96 | 4.72 | 7.77 |
| Net Profit Margin (%) | 4.69 | 10.39 | 4.38 | 3.37 | 5.74 |
| Return on Networth / Equity (%) | 5.35 | 11.23 | 5.03 | 3.74 | 4.73 |
| Return on Capital Employeed (%) | 7.69 | 13.39 | 6.74 | 5.18 | 6.32 |
| Return On Assets (%) | 4.56 | 9.57 | 4.34 | 3.04 | 4.10 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.99 | 0.97 | 0.98 | 0.94 | 0.69 |
| Current Ratio (X) | 3.84 | 3.96 | 3.36 | 3.94 | 5.81 |
| Quick Ratio (X) | 3.10 | 3.38 | 2.67 | 3.40 | 5.35 |
| Inventory Turnover Ratio (X) | 12.67 | 9.24 | 8.96 | 10.88 | 6.97 |
| Interest Coverage Ratio (X) | 56.43 | 118.68 | 69.12 | 57.84 | 67.40 |
| Interest Coverage Ratio (Post Tax) (X) | 31.07 | 84.46 | 39.29 | 29.65 | 37.27 |
| Enterprise Value (Cr.) | 25.36 | 23.59 | 16.85 | 5.92 | 1.20 |
| EV / Net Operating Revenue (X) | 0.51 | 0.53 | 0.39 | 0.15 | 0.04 |
| EV / EBITDA (X) | 5.87 | 3.59 | 5.02 | 2.23 | 0.40 |
| MarketCap / Net Operating Revenue (X) | 0.65 | 0.72 | 0.42 | 0.46 | 0.51 |
| Price / BV (X) | 0.74 | 0.78 | 0.49 | 0.51 | 0.42 |
| Price / Net Operating Revenue (X) | 0.65 | 0.72 | 0.42 | 0.46 | 0.51 |
| EarningsYield | 0.07 | 0.14 | 0.10 | 0.07 | 0.11 |
After reviewing the key financial ratios for Haryana Leather Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.69. This value is below the healthy minimum of 5. It has decreased from 9.41 (Mar 24) to 4.69, marking a decrease of 4.72.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.69. This value is below the healthy minimum of 5. It has decreased from 9.41 (Mar 24) to 4.69, marking a decrease of 4.72.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.52. This value is within the healthy range. It has decreased from 11.17 (Mar 24) to 6.52, marking a decrease of 4.65.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 87.45. It has increased from 83.76 (Mar 24) to 87.45, marking an increase of 3.69.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 87.45. It has increased from 83.76 (Mar 24) to 87.45, marking an increase of 3.69.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 99.89. It has increased from 90.50 (Mar 24) to 99.89, marking an increase of 9.39.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.79. This value is within the healthy range. It has decreased from 13.38 (Mar 24) to 8.79, marking a decrease of 4.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 6.96. This value is within the healthy range. It has decreased from 11.61 (Mar 24) to 6.96, marking a decrease of 4.65.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.80. This value is within the healthy range. It has decreased from 11.50 (Mar 24) to 6.80, marking a decrease of 4.70.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.69. This value is within the healthy range. It has decreased from 9.41 (Mar 24) to 4.69, marking a decrease of 4.72.
- For PBDIT Margin (%), as of Mar 25, the value is 8.80. This value is below the healthy minimum of 10. It has decreased from 14.78 (Mar 24) to 8.80, marking a decrease of 5.98.
- For PBIT Margin (%), as of Mar 25, the value is 6.96. This value is below the healthy minimum of 10. It has decreased from 12.83 (Mar 24) to 6.96, marking a decrease of 5.87.
- For PBT Margin (%), as of Mar 25, the value is 6.81. This value is below the healthy minimum of 10. It has decreased from 12.70 (Mar 24) to 6.81, marking a decrease of 5.89.
- For Net Profit Margin (%), as of Mar 25, the value is 4.69. This value is below the healthy minimum of 5. It has decreased from 10.39 (Mar 24) to 4.69, marking a decrease of 5.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.35. This value is below the healthy minimum of 15. It has decreased from 11.23 (Mar 24) to 5.35, marking a decrease of 5.88.
- For Return on Capital Employeed (%), as of Mar 25, the value is 7.69. This value is below the healthy minimum of 10. It has decreased from 13.39 (Mar 24) to 7.69, marking a decrease of 5.70.
- For Return On Assets (%), as of Mar 25, the value is 4.56. This value is below the healthy minimum of 5. It has decreased from 9.57 (Mar 24) to 4.56, marking a decrease of 5.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.99. It has increased from 0.97 (Mar 24) to 0.99, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 3.84. This value exceeds the healthy maximum of 3. It has decreased from 3.96 (Mar 24) to 3.84, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 3.10. This value exceeds the healthy maximum of 2. It has decreased from 3.38 (Mar 24) to 3.10, marking a decrease of 0.28.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.67. This value exceeds the healthy maximum of 8. It has increased from 9.24 (Mar 24) to 12.67, marking an increase of 3.43.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 56.43. This value is within the healthy range. It has decreased from 118.68 (Mar 24) to 56.43, marking a decrease of 62.25.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 31.07. This value is within the healthy range. It has decreased from 84.46 (Mar 24) to 31.07, marking a decrease of 53.39.
- For Enterprise Value (Cr.), as of Mar 25, the value is 25.36. It has increased from 23.59 (Mar 24) to 25.36, marking an increase of 1.77.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.53 (Mar 24) to 0.51, marking a decrease of 0.02.
- For EV / EBITDA (X), as of Mar 25, the value is 5.87. This value is within the healthy range. It has increased from 3.59 (Mar 24) to 5.87, marking an increase of 2.28.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.72 (Mar 24) to 0.65, marking a decrease of 0.07.
- For Price / BV (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.78 (Mar 24) to 0.74, marking a decrease of 0.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.72 (Mar 24) to 0.65, marking a decrease of 0.07.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 24) to 0.07, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Haryana Leather Chemicals Ltd:
- Net Profit Margin: 4.69%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 7.69% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.35% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 31.07
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.1
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.1 (Industry average Stock P/E: 84.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.69%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | 1405 - B, Signature Towers, South City - I, Gurgaon Haryana 122001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pankaj Jain | Managing Director |
| Mr. Narendra Kumar Jain | Non Executive Director |
| Mr. Vijay Kumar Garg | Non Executive Director |
| Mr. Sippy Jain | Executive Director |
| Mr. Kanishk Gupta | Independent Director |
| Mr. Chinar Goel | Independent Director |
| Ms. Ritu Atri | Independent Director |
| Mr. Pradeep Kumar Verma | Director |
FAQ
What is the intrinsic value of Haryana Leather Chemicals Ltd?
Haryana Leather Chemicals Ltd's intrinsic value (as of 17 February 2026) is ₹60.51 which is 2.39% higher the current market price of ₹59.10, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹29.0 Cr. market cap, FY2025-2026 high/low of ₹88.8/52.0, reserves of ₹39.08 Cr, and liabilities of ₹53.01 Cr.
What is the Market Cap of Haryana Leather Chemicals Ltd?
The Market Cap of Haryana Leather Chemicals Ltd is 29.0 Cr..
What is the current Stock Price of Haryana Leather Chemicals Ltd as on 17 February 2026?
The current stock price of Haryana Leather Chemicals Ltd as on 17 February 2026 is ₹59.1.
What is the High / Low of Haryana Leather Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Haryana Leather Chemicals Ltd stocks is ₹88.8/52.0.
What is the Stock P/E of Haryana Leather Chemicals Ltd?
The Stock P/E of Haryana Leather Chemicals Ltd is 14.1.
What is the Book Value of Haryana Leather Chemicals Ltd?
The Book Value of Haryana Leather Chemicals Ltd is 89.6.
What is the Dividend Yield of Haryana Leather Chemicals Ltd?
The Dividend Yield of Haryana Leather Chemicals Ltd is 1.69 %.
What is the ROCE of Haryana Leather Chemicals Ltd?
The ROCE of Haryana Leather Chemicals Ltd is 8.02 %.
What is the ROE of Haryana Leather Chemicals Ltd?
The ROE of Haryana Leather Chemicals Ltd is 5.45 %.
What is the Face Value of Haryana Leather Chemicals Ltd?
The Face Value of Haryana Leather Chemicals Ltd is 10.0.